Semaglutide and tirzepatide represent distinct receptor profiles within the GLP-1 family
Heres what it means for Medicaid enrollees: Medicaid access through the BALANCE Model could begin as early as May 2026 States must opt in voluntarily its not automatic Participating states receive federally negotiated prices from Eli Lilly (Zepbound, Mounjaro) and Novo Nordisk (Wegovy, Ozempic) Wegovy and Zepbound starting doses would cost the program $350/month (reduced from over $1,000) Patients in participating states would pay $50/month for covered GLP-1s Prior authorization and qualifying criteria will still apply This is the biggest potential expansion of GLP-1 access for Medicaid enrollees in history but it depends on your state deciding to participate
The intake is women-focused, fitting the audience for this drug
127 Hypoxia and metabolic reprogramming within the TME additionally impair T-cell infiltration and function, reinforcing an immunologically cold phenotype
Flushing and head rush immediately after injection of ipamorelin occur in some users but are transient, lasting minutes
While Ive been more consistent about reducing alcohol and caffeine, I still enjoy sweet foods and often use low- and non-nutritive sweeteners to satisfy cravings without completely derailing my health goals